“For the first time in history, a patient was administered an AI-designed virus to treat an infection,” says the biotech startup.

According to the biotechnology startup Radical Numerics, scientists have, for the first time in history, used artificial intelligence (AI)-designed viruses—bacteriophages—to treat a patient with...

Imitating Viral Infection Against Cancer — Israeli Startup ViVac Pharma Wins Hebrew University Award

Biotech startup ViVac Pharma, which is working on a novel method to activate the immune system against cancer, has won the Hebrew University of...

New publication by Georgian scientists: Phage therapy completely eradicated antibiotic-resistant infection in cystic fibrosis

A new article has been published in the international scientific journal Viruses (MDPI), co-authored by researchers from the George Eliava Institute of Bacteriophages, Microbiology...

The FDA has approved a new hepatitis B drug that offers patients a chance to end long-term treatment.

The U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen), a hepatitis B drug developed by the British pharmaceutical company GSK. The new...

Green space near homes reduces dementia risk by 20% — Stockholm University study

According to a joint study by Stockholm University and Karolinska Institutet, older adults living in urban environments with abundant green space within a 100-meter...

Alcohol Drives Brain’s Immune Cells to Break Down Neurons’ Protective Web — Cleveland Clinic Study

Researchers at Cleveland Clinic have uncovered a previously unknown mechanism behind alcohol's effects on the brain. According to a study published in the journal...

The Headphone Generation: Why Prolonged Audio Stimulation Leads to Social Isolation

According to Edison Research data, individuals aged 13 to 34 spend an average of 4.5 hours a day listening to music or podcasts. Furthermore,...

Attention-Deficit/Hyperactivity Disorder (ADHD) is associated with an increased risk of mortality — what role does treatment play?

Attention-Deficit/Hyperactivity Disorder (ADHD) is associated with an elevated risk of premature mortality, but pharmacotherapy can significantly reduce this figure. A major new meta-analysis published...